TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.

Jennifer A Woyach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.